Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value of FEops HEARTguideTM Patient-Specific Computational Simulation in the Planning of Percutaneous Left Atrial Appendage Closure With the AmplatzerTM AmuletTM Device (PREDICT-LAA)

NCT04180605 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT04180605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04180605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value of FEops HEARTguideTM Patient-Specific Computational Simulation in the Planning of Percutaneous Left Atrial Appendage Closure With the AmplatzerTM AmuletTM Device (PREDICT-LAA)
Lead sponsor
Rigshospitalet, Denmark
Phase
Not applicable
Overall status
Unknown status
Start date
January 6, 2020
Completion date
December 31, 2022
Enrollment
200 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, stroke prevention